Last 10Q was in June, so we should be seeing that soon. The one before that was filed on the 11th of March, the one before that on the 10th of December....looking back through 2011 all the reports have been filed mid month, with the annual reports being filed in mid Oct. If that trend holds, then we should be seeing the annual report in a tad less than 30 days.
They mentioned expecting to see the Oral-lyn approval in India around the end of summer, so we should hear something there very soon.
Also, we will hopefully hear of a partnership on the phase III A37 breast cancer vaccine this coming quarter. I am wondering on that one though....am wondering if they might put that off until sales from India start rolling in, so they can fund the phase III themselves without partnering. However, given the spinoff of Antigen, I am leaning to seeing a partnership.
IMO, these next 30 days should prove quite interesting....and hopefully profitable, lol!
GLTA!
News 
Market Data 
Discover 
AI
